Anika Therapeutics (ANIK) Tops Q3 EPS by 3c
ANIK Hot Sheet
Revenue Growth %: +23.1%Financial Fact:
Provision for income taxes: 1.1M
Today's EPS Names:
TARO, BRLI, TLB, More
Anika Therapeutics (NASDAQ: ANIK) reports Q3 EPS of $0.13, 3 cents better than the analyst estimate of $0.10. Revenue for the quarter was $10.8 million, which compares to the estimate of $10.44 million
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- AFC Enterprises, Inc. (AFCE) Tops Q1 EPS by 4c; Raises FY12 Comps Outlook
- Frontline (FRO) Posts Surprise Q1 Profit
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
